Retraction
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Paper Information
Record ID:
55621
Author(s):
Journal:
Publication Date:
May 07, 2019
Retraction Date:
August 10, 2024
(1.3 year years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Medical University of South Carolina, Charleston, SC, USA
- MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA
- Private Practice, Charleston, SC, USA
- University of British Columbia–Okanagan, Kelowna, BC, Canada
- Stanford School of Medicine, Stanford University, Stanford, CA, USA
- Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA
Countries:
Article Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1007/s00213-024-06666-xAdditional Notes:
see also: https://www.statnews.com/2024/08/11/mdma-ptsd-lykos-maps-retractions/
Citations (331)
331
Total Citations32
Post-Retraction(9.7%)
299
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
32
Within 1 year
0
After 2+ years
335
Days since retraction (latest)
MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study
Tor-Morten Kvam, Ivar W Goksøyr, Joanna Róg et al. (11 authors)
The British Journal of Psychiatry
Published: Jul 2025
335 days after retraction
Fear as medicine: A mixed-methods analysis of 5-MeO-DMT, mental health, and intergenerational healing
Jeffrey Overall
Deleted Journal
Published: Jun 2025
320 days after retraction
Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study
Martijn H.B. Koolen, Annika Wirsching, Erwin Krediet et al. (4 authors)
Journal of Psychoactive Drugs
Open Access
Published: Jun 2025
317 days after retraction
Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress
Sean M. Viña
Psychedelic Medicine
Published: Apr 2025
255 days after retraction
Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
Claudio Agnorelli, Meg J. Spriggs, Kate Godfrey et al. (11 authors)
Neuroscience & Biobehavioral Reviews
Open Access
Published: Apr 2025
3 citations
3 citations
237 days after retraction
Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness
Sean M. Viña
Drug Science Policy and Law
Published: Apr 2025
234 days after retraction
Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use
Steven Elfrink, Leigh Bergin
Frontiers in Psychology
Open Access
Published: Mar 2025
206 days after retraction
Bioproduction of 3,4-methylenedioxymethamphetamine and derivatives
Natali Özber, Jing Li, Peter J. Facchini
BioDesign Research
Open Access
Published: Mar 2025
203 days after retraction
Social Worker Attitudes towards Psychedelics
Eva Nowakowski-Sims, Joshua Holzworth
Clinical Social Work Journal
Open Access
Published: Feb 2025
180 days after retraction
Phase 1 Clinical Trial on Orgasmic Meditation (OM): Assessing Safety and Feasibility as a Meditation Practice for Individuals with PTSD
Daniel Kriegman, Rachel Pelletier, Caroline Griggs et al. (4 authors)
Contemporary Clinical Trials Communications
Open Access
Published: Feb 2025
175 days after retraction
Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects
Carrie Cuttler, Amanda Stueber, Jonathan J. Simone et al. (4 authors)
Journal of Psychoactive Drugs
Published: Jan 2025
172 days after retraction
Qualitative Analysis of Views of Psychedelic-Assisted Therapy in Low-Income, Urban, Black Americans
Sierra Carter, Grace Packard, Jessica L. Maples‐Keller
Psychedelic Medicine
Published: Jan 2025
157 days after retraction
Post-traumatic stress disorder in psychedelic research
Tijmen Bostoen, Stephan Tap, Joost J. Breeksema et al. (4 authors)
International review of neurobiology
Published: Jan 2025
144 days after retraction
Traumatic Psychedelic Experiences
Abigail E. Calder, Vincent J Diehl, Gregor Hasler
Current topics in behavioral neurosciences
Published: Jan 2025
144 days after retraction
MDMA and MDMA-Assisted Therapy
Aaron Wolfgang, Gregory A. Fonzo, Joshua C. Gray et al. (10 authors)
American Journal of Psychiatry
Published: Jan 2025
9 citations
9 citations
144 days after retraction
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration
Aaron Wolfgang, Vetisha L. McClair, Paula P. Schnurr et al. (16 authors)
American Journal of Psychiatry
Published: Jan 2025
1 citation
1 citation
144 days after retraction
Serotonergic psychedelics for depression: A comprehensive overview
Aleksandra Wingert, C. Agnorelli, Joseph Peill et al. (6 authors)
International review of neurobiology
Published: Jan 2025
144 days after retraction
Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review
Rafael Vitor Lima da Cruz, Richardson N. Leão, Thiago C. Moulin
Molecular Medicine
Open Access
Published: Dec 2024
4 citations
4 citations
131 days after retraction
Effectiveness of Pharmacological Treatment for PTSD
Dev Vyas, Shraddha Tripathi, D S Goel
Advances in medical diagnosis, treatment, and care (AMDTC) book series
Published: Dec 2024
125 days after retraction
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies
Michel Sabé, Adi Sulstarova, Alban Glangetas et al. (18 authors)
Molecular Psychiatry
Open Access
Published: Nov 2024
5 citations
5 citations
109 days after retraction
The historical opposition to psychedelic research and implications for credibility in psychiatry
Elena Koning, Elvina Chu, Elisa Brietzke
CNS Spectrums
Open Access
Published: Nov 2024
1 citation
1 citation
103 days after retraction
Psychedelic medicine and cultural responsiveness: A call for Aboriginal and Torres Strait Islander engagement in Australian clinical trials and practice
Bianca Sebben, Jem Stone, Jerome Sarris et al. (8 authors)
Australian and New Zealand Journal of Public Health
Open Access
Published: Nov 2024
1 citation
1 citation
89 days after retraction
Religious Social Integration, Psychedelics, and Psychological Distress
Sean M. Viña
Journal of Psychoactive Drugs
Published: Nov 2024
2 citations
2 citations
89 days after retraction
The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD
Kelley C. O’Donnell, Lauren Okano, Michael Alpert et al. (9 authors)
Frontiers in Psychology
Open Access
Published: Nov 2024
12 citations
12 citations
86 days after retraction
<scp>MDMA</scp>‐assisted psychotherapy for the treatment of <scp>PTSD</scp>: A systematic review and meta‐analysis of randomized controlled trials (<scp>RCTs</scp>)
Ghada Shahrour, Kainat Sohail, Safa Elrais et al. (11 authors)
Neuropsychopharmacology Reports
Open Access
Published: Oct 2024
5 citations
5 citations
60 days after retraction
Mechanisms of psilocybin on the treatment of posttraumatic stress disorder
Charles Q. Choi, Danica E. Johnson, David Chen‐Li et al. (4 authors)
Journal of Psychopharmacology
Published: Oct 2024
3 citations
3 citations
54 days after retraction
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use
Nicolas G. Glynos, Anne Baker, Jacob S. Aday et al. (8 authors)
Journal of Psychoactive Drugs
Published: Sep 2024
1 citation
1 citation
40 days after retraction
Exploring the Regulatory Framework of Psychedelics in the US & Europe
Hitesh Kumar Behera, Ramesh Joga, Sravani Yerram et al. (11 authors)
Asian Journal of Psychiatry
Published: Sep 2024
8 citations
8 citations
38 days after retraction
Beyond Pharmacology: A Narrative Review of Alternative Therapies for Anxiety Disorders
Z Antoś, Klaudia Zackiewicz, Natalia Tomaszek et al. (5 authors)
Diseases
Open Access
Published: Sep 2024
1 citation
1 citation
37 days after retraction
The Psychedelic Renaissance: A Catholic Perspective
Thomas Carroll
The Linacre Quarterly
Published: Sep 2024
1 citation
1 citation
36 days after retraction
Psychoactive substances for the treatment of neuropsychiatric disorders
Zifan Zhen, Xueqiang Sun, Shiying Yuan et al. (4 authors)
Asian Journal of Psychiatry
Published: Sep 2024
4 citations
4 citations
24 days after retraction
FDA rejects ecstasy as a therapy: what’s next for psychedelics?
Sara Reardon
Nature
Published: Aug 2024
8 citations
8 citations
3 days after retraction
Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design
Pablo Miranda, Analía Castro, Paola Díaz et al. (8 authors)
Polymers
Open Access
Published: Jul 2024
1 citation
1 citation
12 days before retraction
PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin
Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa et al. (7 authors)
Journal of Advances in Medicine and Medical Research
Open Access
Published: Jul 2024
17 days before retraction
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials
Ronit Kishon, Nadav Liam Modlin, Yael M. Cycowicz et al. (8 authors)
npj Mental Health Research
Open Access
Published: Jul 2024
9 citations
9 citations
39 days before retraction
Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System
Tigran Makunts, Ruben Abagyan
Frontiers in Psychiatry
Open Access
Published: Jun 2024
1 citation
1 citation
53 days before retraction
An Alternative Approach in the Treatment of Anxiety Disorders: Current Directions
Z Antoś, Klaudia Zackiewicz, Natalia Tomaszek et al. (5 authors)
Unknown Journal
Open Access
Published: Jun 2024
1 citation
1 citation
53 days before retraction
The Conceptual Framework for the Therapeutic Approach used in Phase 3 Trials of MDMA-AT for PTSD
Kelley C. O’Donnell, Michael Alpert, Lauren Okano et al. (9 authors)
Unknown Journal
Open Access
Published: Jun 2024
54 days before retraction
Licit use of illicit drugs for treating depression: the pill and the process
Alejandro Torrado Pacheco, Bita Moghaddam
Journal of Clinical Investigation
Open Access
Published: Jun 2024
1 citation
1 citation
55 days before retraction
Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress
Sean M. Viña
Psychoactives
Open Access
Published: Jun 2024
5 citations
5 citations
69 days before retraction
Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial
Chiranth Bhagavan, Paul Glue, Will Evans et al. (11 authors)
Trials
Open Access
Published: May 2024
4 citations
4 citations
81 days before retraction
Minorities’ Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians
Sean M. Viña
Journal of Racial and Ethnic Health Disparities
Open Access
Published: May 2024
9 citations
9 citations
86 days before retraction
The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns
Brian A. Baldo
Archives of Toxicology
Published: May 2024
2 citations
2 citations
88 days before retraction
Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review
Zijia Yu, Lisa Burback, Olga Winkler et al. (14 authors)
Frontiers in Psychiatry
Open Access
Published: May 2024
10 citations
10 citations
88 days before retraction
Psychedelics Use and the Risk of Reduced Formal Mental Health Care
Sean M. Viña
Research Square (Research Square)
Open Access
Published: May 2024
89 days before retraction
Religion, Psychedelics, Risky Behavior, and Violence
Sean M. Viña
Journal of Psychoactive Drugs
Published: Apr 2024
6 citations
6 citations
107 days before retraction
Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis
Julia Colcott, Alexandre Guerin, Olivia Carter et al. (5 authors)
Neuropsychopharmacology
Open Access
Published: Apr 2024
10 citations
10 citations
109 days before retraction
Antianxiety Agents
Unknown Authors
American Psychiatric Association Publishing eBooks
Published: Apr 2024
127 days before retraction
MDMA-gestützte Therapie
Laura Bechtold, Dimitris Repantis
Nervenheilkunde
Published: Apr 2024
131 days before retraction
Trauma Under Psychedelics: MDMA Shows Protective Effects During the Peritraumatic Period
Ophir Netzer, Noa Magal, Yonatan Stern et al. (7 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2024
3 citations
3 citations
132 days before retraction
Quick Stats
Total Citations:
331
Years Since Retraction:
1.3 year
Open Access:
Yes
Last Checked:
Jul 24, 2025